Technology
VenoStent has a new technology to improve outcomes for dialysis patients – Yahoo Lifestyle Australia
Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients. Failed dialysis surgeries occur …
Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients.
Failed dialysis surgeries occur in roughly 55% to 65% of patients with end-stage renal disease, according to the company. Caring for these patients can cost the Medicare and Medicaid Services system roughly $2 billion per year — and Bouré and Lucks believed that they’d co…
-
General11 hours agoWA Police investigate death of baby in Baldivis in Perth’s southern suburbs
-
Noosa News21 hours agoAnna Creek Station owners charged for alleged illegal dams
-
Noosa News17 hours agoBrisbane bus driver found guilty over CBD crash that killed Tia Cameron
-
Noosa News15 hours agoBus driver found guilty over death of 18yo Tia Cameron